Natriuretic Peptides and Troponins to Predict Cardiovascular Events in Patients Undergoing Major Non-Cardiac Surgery
- PMID: 35564577
- PMCID: PMC9103429
- DOI: 10.3390/ijerph19095182
Natriuretic Peptides and Troponins to Predict Cardiovascular Events in Patients Undergoing Major Non-Cardiac Surgery
Abstract
Patients undergoing major surgery have a substantial risk of cardiovascular events during the perioperative period. Despite the introduction of several risk scores based on medical history, classical risk factors and non-invasive cardiac tests, the possibility of predicting cardiovascular events in patients undergoing non-cardiac surgery remains limited. The cardiac-specific biomarkers, natriuretic peptides (NPs) and cardiac troponins (cTn) have been proposed as additional tools for risk prediction in the perioperative period. This review paper aims to discuss the value of preoperative levels and perioperative changes in cardiac-specific biomarkers to predict adverse outcomes in patients undergoing major non-cardiac surgery. Based on several prospective observational studies and six meta-analyses, some guidelines recommended the measurement of NPs to refine perioperative cardiac risk estimation in patients undergoing non-cardiac surgery. More recently, several studies reported a higher mortality in surgical patients presenting an elevation in high-sensitivity cardiac troponin T and I, especially in elderly patients or those with comorbidities. This evidence should be considered in future international guidelines on the evaluation of perioperative risk in patients undergoing major non-cardiac surgery.
Keywords: cardiac natriuretic peptides; cardiac troponins; cardiovascular risk; high-sensitivity methods; non-cardiac surgery.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Devereaux P.J., Goldman L., Cook D.J., Gilbert K., Leslie K., Guyatt G.H. Perioperative cardiac events in patients undergoing noncardiac surgery: A review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. Can. Med. Assoc. J. 2005;173:627–634. doi: 10.1503/cmaj.050011. - DOI - PMC - PubMed
-
- Struthers A., Lang C. The potential to improve primary prevention in the future by using BNP/N-BNP as an indicator of silent ‘pancardiac’ target organ damage: BNP/N-BNP could become for the heart what microalbuminuria is for the kidney. Eur. Heart J. 2007;28:1678–1682. doi: 10.1093/eurheartj/ehm234. - DOI - PubMed
-
- Poldermans D., Bax J.J., Boersma E., De Hert S., Eeckhout E., Fowkes G., Gorenek B., Hennerici M.G., Iung B., Kelm M., et al. Task force for preoperative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery; European Society of Cardiology (ESC). Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur. Heart J. 2009;30:2769–2812. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
